Why is it taking so long to develop clinically competitive stem cell therapies for CNS disorders?
The remarkable advancements in basic stem cell research with implications for several central nervous system disorders have so far not been translated into clinically effective therapies. Here I discuss some of the underlying problems and how they could be overcome.